PATENT CLAIM ANALYSIS

Application Number: 15987458
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "237000"]

Abstract:
The present invention relates to a class of substituted triazolopiperazine compounds, tautomers, enantiomers, diastereomers, racemates, metabolites, metabolic precursors, and pharmaceutically acceptable salts, esters, prodrugs or hydrate thereof, a preparation methods therefor, intermediates and a use thereof in the preparation of drugs for prevention and treatment of diseases associated with PARP including various ischemic diseases, neurodegenerative diseases and cancers.

Claim (Index 7):
Use of the substituted triazolopiperazine compound represented by formula (I) according to  claim 1 , tautomers, enantiomers, diastereomers, racemates, metabolites, metabolic precursors, pharmaceutically acceptable salts, esters, prodrugs or hydrates thereof, as a highly selective PARP-1 inhibitor.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 1.44898
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14418705', '15708917', '13035640', '16060701', '11849230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8110196342784302
- 35 USC 102 Novelty (BERT): 0.5471797436735203
- Combined Prediction Score: 0.7846356452179392
- Mean Citation Score: 337.94636
- Max Citation Score: 431.5869
- Similarity Product: 294.82364191178084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test